期刊文献+

抗磷脂抗体和抗凝蛋白系统与系统性红斑狼疮血栓前状态的关系 被引量:3

The relationship of prethrombotic state with antiphospholipid antibody and anticoagulant protein system in systemic lupus erythematosus patients
下载PDF
导出
摘要 目的探讨抗磷脂抗体和抗凝蛋白系统与系统性红斑狼疮(SLE)血栓前状态的关系。方法蛋白C(PC)测定采用酶联免疫法(ELISA)、凝固法测定蛋白S(PS)活性、抗心磷脂抗体(ACA)检测采用金标法,狼疮抗凝物(LA)检测采用激活的部分凝血活酶时间(PTT)测定法。结果SLE患者蛋白S、蛋白C活性显著下降,狼疮抗凝物(LA)增加,抗心磷脂抗体(ACA)阳性率增加,表现为抗凝蛋白系统功能减弱;同时LA和ACA与PS、PC有显著的负相关性。结论LA和ACA可能是导致PS、PC活性下降的重要因素之一,而PS、PC活性下降可能进一步诱发血栓。因此,抗磷脂抗体和抗凝蛋白系统的联合检测对SLE并发血栓可能有预测价值。 Objective To investigate the relationship of prethrombotic state with antiphospholipid antibody and anticoagulant protein system in systemic lupus erythematosus ( SLE ) patients. Methods Protein C ( PC ) are detected by enzymelinked immunosorbent assay (ELISA) ; the activity of protein S (PS) is detected by coagulation method; anticardolipin antibodies (ACA) are detected by golden standard method; lupus anticoagulant (LA) is deteted by activated partial thromboplastin time method. Results The activity of PS and PC in systemic lupus erythematosus patients significantly decrease; lupus anticoagulant level is enhanced and anticardolipin antibodies are dectected positively; furthermore, LA and ACA are remarkably negatively associated with the level of PS and PC. Conclusion The results indicated that LA and ACA are probably the key clement to cause the activity decrease of PS and PS, which maybe induce thrombus in systemic lupus erythematosus patients. Therefore, combined determination of antiphospholipid antibody and anticoagulant protein system should be a valuable forecast for SLE; patients with thrombus complication.
出处 《广州医药》 2009年第1期60-62,共3页 Guangzhou Medical Journal
关键词 系统性红斑狼疮 血栓前状态 抗磷脂抗体 抗凝蛋白系统 Systemic lupus erythematosus Prethrombotic state Antiphospholipid antibody Anticoagulant protein system
  • 相关文献

参考文献7

  • 1Vaya A, Santaolaria M, Mico L, et al. Trombotic events in systemic lupus erythematosus: Its assocaiation with acquired and inherited thrombophilic defects [ J ] . Ciln Hemorheol Microcirc, 2008, 40 (2): 79-87.
  • 2Mareiniak E, Romond E. Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticogulant [J] . Blood, 1989, 74: 2426-2432.
  • 3Male C, Mitchell L, Julian J, et al. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus [ J ] . Blood, 2001, 97 (4) : 844-849.
  • 4厉小梅,李向培,周志中,吴竞生,单曙光.系统性红斑狼疮患者抗活化蛋白C测定及其临床意义[J].中华内科杂志,2000,39(2):97-99. 被引量:7
  • 5吴竞生,周志中,李向培,厉晓梅,陈育华,汪国生,徐修才,王祖贻.抗磷脂血栓综合征与获得性抗活化的蛋白C现象[J].中华血液学杂志,2000,21(3):122-124. 被引量:12
  • 6Viveros ME, Cabiedes J, Reyes E, et al. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies [ J ] . Rev Invest Clin, 2005, 57 (4): 563-571.
  • 7Aznar J, Villa P, Espana F, et al. Activated protein C resistance phenotype in patients with antiphospholipid antibodies [J] . J Lab Clin Med, 1997, 130: 202-208.

二级参考文献2

共引文献12

同被引文献72

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部